The consumption of bread enriched with betaglucan reduces LDL-cholesterol and improves insulin resistance in patients with type 2 diabetes

Diabetes and Metabolism

Volumn 35, Issue 2, 2009, Pages 115-120

  Liatis, S ^a   Tsapogas, P ^a   Chala, E ^b   Dimosthenopoulos, C ^a   Kyriakopoulos, K ^a   Kapantais, E ^b   Katsilambros, N ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b METROPOLITAN HOSPITAL   (Greece)

Author keywords

Betaglucan; Cholesterol; Insulin resistance; Oat bran; Type 2 diabetes

Indexed keywords

BETA GLUCAN; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; BREAD; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC PATIENT; DIETARY INTAKE; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; INSULIN RESISTANCE; LIPOPROTEIN BLOOD LEVEL; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; RANDOMIZED CONTROLLED TRIAL;

AGED; BETA-GLUCANS; BLOOD GLUCOSE; BREAD; CHOLESTEROL; CHOLESTEROL, LDL; DIABETES MELLITUS, TYPE 2; DOUBLE-BLIND METHOD; FEMALE; FOOD, FORTIFIED; HUMANS; INSULIN RESISTANCE; LINEAR MODELS; LIPID METABOLISM; MALE; MIDDLE AGED;

EID: 64149092573     PISSN: 12623636     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabet.2008.09.004     Document Type: Article

References (29)

1. US Food and drug administration: FDA final rule for federal labelling: health claims: oats and coronary heart disease. Fed Regist 1997;62:3584-681.
2. De Groot A.P., Luyken R., and Pikaar N.A. Cholesterol-lowering effect of rolled oats. Lancet 2 (1963) 303-304
3. Anderson J.W., Gilinsky N.H., Deakins D.A., Smith S.F., O'Neal D.S., Dillon D.W., et al. Lipid responses of hypercholesterolemic men to oat-bran and wheat-bran intake. Am J Clin Nutr 54 (1991) 678-683
4. Keenan J.M., Wenz J.B., Myers S., Ripsin C., and Huang Z.Q. Randomized, controlled, crossover trial of oat bran in hypercholesterolemic subjects. J Fam Pract 33 (1991) 600-608
5. Davidson M.H., Dugan L.D., Burns J.H., Bova J., Story K., and Drennan K.B. The hypocholesterolemic effects of betaglucan in oat meal and oat bran. A dose-controlled study. JAMA 265 (1991) 1833-1839
6. Braaten J.T., Wood P.J., Scott F.W., Wolynetz M.S., Lowe M.K., Bradley-White P., et al. Oat betaglucan reduces blood cholesterol concentration in hypercholesterolemic subjects. Eur J Clin Nutr 48 (1994) 465-474
7. Ripsin C.M., Keenan J.M., Jacobs D.R., Elmer P.J., Welch R.R., Van Horn L., et al. Oat products and lipid lowering. A meta-analysis. JAMA 267 (1992) 3317-3325
8. Position statement. Standards of medical care in diabetes 2007, American diabetes association. Diabetes Care 30 (2007) S4-S41
9. Braaten J.T., Scott F.W., Wood P.J., Riedel K.D., Wolynetz M.S., Brulé D., et al. High betaglucan oat bran and oat gum reduce postprandial blood glucose and insulin in subjects with and without type 2 diabetes. Diabet Med 11 (1994) 312-318
10. Pick M.E., Hawrysh Z.J., Gee M.I., Toth E., Garg M.L., and Hardin R.T. Oat bran concentrate bread products improve long-term control of diabetes: a pilot study. J Am Diet Assoc 96 (1996) 1254-1261
11. Biörklund M., van Rees A., Mensink R.P., and Onning G. Changes in serum lipids and postprandial glucose and insulin concentrations after consumption of beverages with betaglucans from oats or barley: a randomised dose-controlled trial. Eur J Clin Nutr 59 (2005) 1272-1281
12. Tapola N., Karvonen H., Niskanen L., Mikola M., and Sarkkinen E. Glycemic responses of oat bran products in type 2 diabetic patients. Nutr Metab Cardiovasc Dis 15 (2005) 255-261
13. Jenkins A.L., Jenkins D.J., Zdravkovic U., Würsch P., and Vuksan V. Depression of the glycemic index by high levels of betaglucan fiber in two functional foods tested in type 2 diabetes. Eur J Clin Nutr 56 (2002) 622-628
14. Tappy L., Gügolz E., and Würsch P. Effects of breakfast cereals containing various amounts of betaglucan fibers on plasma glucose and insulin responses in NIDDM subjects. Diabetes Care 19 (1996) 831-834
15. Rami B., Zidek T., and Schober E. Influence of a betaglucan-enriched bedtime snack on nocturnal blood glucose levels in diabetic children. J Pediatr Gastroenterol Nutr 32 (2001) 34-36
16. Mann J.I., De Leeuw I., Hermansen K., Karamanos B., Karlström B., Katsilambros N., et al., Diabetes and nutrition study group (DNSG) of the European association. Evidence-based nutritional approaches to the treatment and prevention of diabetes mellitus. Nutr Metab Cardiovasc Dis 14 (2004) 373-394
17. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., and Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-419
18. Gould A.L., Rossouw J.E., Santanello N.C., Heyse J.F., and Furberg C.D. Cholesterol reduction yields clinical benefit: impact of statin trials. Circulation 97 (1998) 946-952
19. Lu W., Resnick H.E., Jablonski K.A., Jones K.L., Jain A.K., Howard W.J., et al. Non-HDL cholesterol as a predictor of cardiovascular disease in type 2 diabetes: the strong heart study. Diabetes Care 26 (2003) 16-23
20. Executive. Summary of the third report of the National cholesterol education program (NCEP) Expert panel on detection, evaluation, and treatment of high blood cholesterol in adult (Adult treatment panel III). JAMA 285 (2001) 2486-2497
21. Kinosian B., Glick H., and Garland G. Cholesterol and coronary heart disease: predicting risks by levels and ratios. Ann Intern Med 121 (1994) 641-647
22. Lia A., Andersson H., Mekki N., Juhel C., Senft M., and Lairon D. Postprandial lipemia in relation to sterol and fat excretion in ileostomy subjects given oat-bran and wheat test meals. Am J Clin Nutr 66 (1997) 357-365
23. Andersson M., Ellegård L., and Andersson. Oat bran stimulates bile acid synthesis within 8 h as measured by 7 alpha-hydroxy-4-cholesten-3-one. Am J Clin Nutr 76 (2002) 1111-1116
24. Kerckhoffs D.A., Brouns F., Hornstra G., and Mensink R.P. Effects on the human serum lipoprotein profile of betaglucan, soy protein and isoflavones, plant sterols and stanols, garlic and tocotrienols. J Nutr 132 (2002) 2494-2505
25. Reyna-Villasmil N., Bermúdez-Pirela V., Mengual-Moreno E., Arias N., Cano-Ponce C., Leal-Gonzalez E., et al. Oat-derived betaglucan significantly improves HDL-C and diminishes LDL-C and non-HDL cholesterol in overweight individuals with mild hypercholesterolemia. Am J Ther 14 (2007) 203-212
26. Pi-Sunyer. A review of long-term studies evaluating the efficacy of weight loss in ameliorating disorders associated with obesity. Clin Ther 18 (1996) 1006-1035
27. Würsch P., Pi-Sunyer F.X., Würsch P., and Pi-Sunyer F.X. The role of viscous soluble fiber in the metabolic control of diabetes. A review with special emphasis on cereals rich in betaglucan. Diabetes Care 20 (1997) 1774-1780
28. Chandalia M., Garg A., Lutjohann D., von Bergmann K., Grundy S.M., and Brinkley L.J. Beneficial effects of high dietary fiber intake in patients with type 2 diabetes mellitus. N Engl J Med 342 (2000) 1392-1398
29. Pins J.J., Geleva D., Keenan J.M., Frazel C., O'Connor P.J., and Cherney L.M. Do whole-grain oat cereals reduce the need for antihypertensive medications and improve blood pressure control?. J Fam Pract 51 (2002) 353-359